FIPIQU

Serial Number 79311367
Registration 6488841
700

Registration Progress

Application Filed
Mar 12, 2021
Under Examination
Approved for Publication
Jun 16, 2021
Published for Opposition
Jul 6, 2021
Registered
Sep 21, 2021

Trademark Image

FIPIQU

Basic Information

Serial Number
79311367
Registration Number
6488841
Filing Date
March 12, 2021
Registration Date
September 21, 2021
Published for Opposition
July 6, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 21, 2021
Registration
Registered
Classes
005

Rights Holder

TAIHO PHARMACEUTICAL CO., LTD.

03
Address
1-27 Kandanishiki-cho,
Chiyoda-ku Tokyo 101-8444
JP

Ownership History

TAIHO PHARMACEUTICAL CO., LTD.

Original Applicant
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Owner at Publication
03
JP

TAIHO PHARMACEUTICAL CO., LTD.

Original Registrant
03
JP

USPTO Deadlines

Next Deadline
637 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20210921)
Due Date
September 21, 2027
Grace Period Ends
March 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Dec 18, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Nov 29, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Nov 29, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Oct 21, 2021 GPAR P GRANT OF PROTECTION CREATED, TO BE SENT TO IB Loading...
Sep 21, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 6, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 16, 2021 NPUB O NOTICE OF PUBLICATION Loading...
Jun 3, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 2, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 1, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 26, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 25, 2021 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
May 20, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005